Robert M. Anthenelli, M.D.

 


Robert M. Anthenelli, MD is Professor and Executive Vice Chair in the Department of Psychiatry at the University of California, San Diego, School of Medicine where he directs the Pacific Treatment and Research Center. He previously served as the Associate Chief of Staff for Mental Health at the VA San Diego Healthcare System and Vice Chair for Veterans Affairs. He was formerly a Professor of Psychiatry, Psychology and Neuroscience at the University of Cincinnati, College of Medicine and Cincinnati VA Medical Center where he founded and directed the Center for Treatment, Research & Education in Addictive Disorders, Addiction Sciences Division, and nationally acclaimed Cincinnati VA Substance Dependence Program.

Dr. Anthenelli earned his baccalaureate degree from The Johns Hopkins University in Baltimore, Maryland, USA and his MD degree from The Johns Hopkins University School of Medicine. After graduating medical school, he completed his internship in internal medicine at Mercy Hospital in Baltimore. Dr. Anthenelli did residency training in psychiatry at the University of California, San Diego, School of Medicine. Additional post-doctoral training included a 2-year fellowship in addiction psychiatry research that was funded by the Department of Veterans Affairs.

The overarching theme of Dr. Anthenelli's research is to develop improved treatments for tobacco, alcohol use, and comorbid psychiatric disorders by better understanding the neurobiology of these disorders. He has authored or co-authored over 200 published research articles, book chapters, and abstracts published in major journals including The Lancet, Annals of Internal Medicine, and The American Journal of Psychiatry. Funding for his research is provided by the National Institute on Alcohol Abuse and Alcoholism, the National Institute on Drug Abuse, the Department of Veterans Affairs, and various industry sponsors. He has lectured widely across the globe and is the Principal Investigator and Steering Committee Chair for the EAGLES trial – the largest placebo-controlled smoking cessation pharmacotherapy trial conducted to date.

 

Board of Directors
 
Management Team
 
Board Sub Committees